Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Abeona Therapeutics Inc
F:PCJ
Abeona Therapeutics Inc
F:PCJ
Price:
3.851
EUR
-3.89%
Market Cap:
€157.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abeona Therapeutics Inc
F:PCJ
|
US |
|
C
|
Carlisle Companies Inc
DUS:CLE
|
US |
|
A
|
AzTech WB Co Ltd
KOSDAQ:032080
|
KR |
Wall St Price Targets
PCJ Price Forecast
Based on 11 analysts
Based on 11 analysts
+374% Upside
from
€3.851
today
Abeona Therapeutics Inc (PCJ)’s 12-month stock price forecast through November 2027 has a consensus target of €18.257, implying 374% upside. The forecast is based on price targets from 11 Wall Street analysts.
PCJ Analyst Rating
No ratings yet
No ratings yet
Abeona Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCJ's stock price target?
Price Target
18.257
EUR
18.257
EUR
According to Wall Street analysts, the average 1-year price target for PCJ is 18.257 EUR with a low forecast of 14.888 EUR and a high forecast of 33.166 EUR.
What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
69%
69%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 69%.
What is the Gross Profit forecast for Abeona Therapeutics Inc?
Projected CAGR
185%
185%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 185%.
What is the Pre-Tax Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-23%
-23%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -23%.
What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
18%
18%
The compound annual growth rate for Net Income over the next 8 years is 18%.